VCCClogo

Professor Doug Hanahan and Associate Professor Kate Burbury, Peter Mac, discuss the hallmarks of cancer and impact on advanced treatments. A recent study has discovered which proteins activate genes, and in another, real time imaging showed reactions to chemotherapy differs depending on type of cancer cell mutation.

The European Medicines Agency has questioned trial designs and approvals for 32 new cancer drugs; researchers emphasised the ‘risk’ of bias due to the complex nature of cancer trials.

 
Tuesday 17 September - Monday 23 September
The Medical News • Sep 21, 2019  2:57
In the body's cells, some proteins are of vital importance as to which genes are active or turned off. Now, researchers from the University...
or turned off. Now, researchers from the University of Copenhagen and the Memorial Sloan Kettering Cancer Center have discovered which
 
The Medical News • Sep 20, 2019  22:40
New research led by the University of South Australia shows just how effective bowel cancer screening is in helping to reduce the number of...
New research led by the University of South Australia shows just how effective bowel cancer screening is in helping to reduce the number of
 
https://www.nationaltribune.com.au • Sep 20, 2019  12:3
The Palaszczuk Government is investing in a key science facility that is at the forefront of research into the battle against the third...
science facility that is at the forefront of research into the battle against the third most common cancer diagnosed in Australia, melanoma.
 
EZ Australia • Sep 20, 2019  6:39
by Dr. Belinda Lee Honorary, Medical Biology (W.E.H.I.) Pancreatic cancer is the fifth most common cause of cancer death in Australia and...
The program is a collaborative effort between the Walter and Eliza Hall Institute, University of Melbourne, and 11 Victorian cancer centres.
 
The Medical News • Sep 20, 2019  3:34
Early palliative care is associated with better survival in patients with advanced lung cancer, according to a study by VA Portland Health...
Early palliative care linked to better survival in patients with advanced lung cancer
 
Science Media Exchange - Scimex • Sep 19, 2019  8:53
About half of trials that supported new cancer drug approvals had flaws in their trial design, according to researchers examining trials...
of trials that supported new cancer drug approvals had flaws in their trial design, according to researchers examining trials between 2014
 
The Canberra Times (Licensed by Copyright Agency) • Sep 18, 2019  16:30
Looking perennially youthful eight days before her 71st birthday and in good spirits despite reportedly battling...
the Olivia Newton-John Cancer Research Institute & Minderoo, on the success of the rare cancer clinical trials being delivered at the ONJCRI
 
ABC News • Sep 18, 2019  8:7
Image: Professor Doug Hanahan, pictured in a lab in Melbourne. (Victorian Comprehensive Cancer Centre: Lee Byrne) In 2000, Professor Doug...
Professor Doug Hanahan, pictured in a lab in Melbourne. (Victorian Comprehensive Cancer Centre: Lee Byrne) In 2000, Professor Doug Hanahan
 
Science Media Exchange - Scimex • Sep 17, 2019  19:23
Researchers at Children’s Medical Research Institute in Sydney have demonstrated why chemotherapy drugs work better with some types of...
Discovering why chemotherapy only works for some cancer patients